Citadel Advisors’s Enovix ENVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.07M Buy
785,329
+588,873
+300% +$3.69M ﹤0.01% 4683
2025
Q4
$1.44M Sell
196,456
-1,476,323
-88% -$14.3M ﹤0.01% 6614
2025
Q3
$16.7M Buy
+1,672,779
New +$18.5M ﹤0.01% 2570
2025
Q2
Sell
-2,039,190
Closed -$13.3M 13180
2025
Q1
$13.1M Sell
2,039,190
-278,393
-12% -$2.48M ﹤0.01% 2525
2024
Q4
$22M Buy
2,317,583
+1,579,808
+214% +$13.9M ﹤0.01% 2065
2024
Q3
$6.03M Sell
737,775
-1,512,474
-67% -$15.7M ﹤0.01% 3650
2024
Q2
$30.4M Sell
2,250,249
-654,602
-23% -$5.47M 0.01% 1588
2024
Q1
$20.4M Buy
2,904,851
+1,749,194
+151% +$15.2M ﹤0.01% 2043
2023
Q4
$12.7M Sell
1,155,657
-390,894
-25% -$3.84M ﹤0.01% 2542
2023
Q3
$17M Buy
1,546,551
+790,354
+105% +$11.3M ﹤0.01% 2041
2023
Q2
$11.9M Buy
756,197
+418,894
+124% +$4.87M ﹤0.01% 2449
2023
Q1
$4.4M Sell
337,303
-297,648
-47% -$2.44M ﹤0.01% 4022
2022
Q4
$6.91M Buy
634,951
+453,992
+251% +$5.59M ﹤0.01% 3345
2022
Q3
$2.9M Sell
180,959
-75,816
-30% -$1.12M ﹤0.01% 4863
2022
Q2
$2M Sell
256,775
-266,511
-51% -$2.51M ﹤0.01% 5541
2022
Q1
$6.53M Buy
523,286
+262,696
+101% +$3.68M ﹤0.01% 3666
2021
Q4
$6.22M Buy
260,590
+225,185
+636% +$5.45M ﹤0.01% 3909
2021
Q3
$585K Buy
+35,405
New +$533K ﹤0.01% 9483

Other funds holding ENVX

Citadel Advisors's ENVX Position: Q1 2026 in Review

Citadel Advisors increased its Enovix (ENVX) stake by 300% in Q1 2026, buying an estimated $3.69M and bringing the position to 785,329 shares worth $4.07M. The position accounts for ﹤0.01% of the portfolio, ranked #4683.

Citadel Advisors first reported a position in ENVX in Q3 2021 and has held it in 18 quarters since. The position peaked at $30.4M in Q2 2024. 306 funds tracked by Wall St. Rank hold ENVX as of Q1 2026.

  • Citadel Advisors held 785,329 shares of Enovix worth $4.07M as of Q1 2026.
  • Citadel Advisors bought 588,873 Enovix shares in Q1 2026, an estimated $3.69M.
  • Enovix made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #4683 holding.
  • Citadel Advisors first reported a position in Enovix in Q3 2021 and has held it in 18 quarters since.
  • Citadel Advisors's Enovix position peaked at $30.4M in Q2 2024.
  • 306 funds tracked by Wall St. Rank held Enovix as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.